Charles D. Smith

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase II trial of opaganib in patients with metastatic castration-resistant prostate cancer progressing on abiraterone or enzalutamide (NCT04207255).”.

Phase II trial of opaganib in patients with metastatic castration-resistant prostate cancer progressing on abiraterone or enzalutamide (NCT04207255).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps191

N/A

0DataRank · unranked

3 citations

Charles D. Smith, Terry F. Plasse, Besim Öğretmen, Shikhar Mehrotra, Theodore Stewart Gourdin +6 more

Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma Cells

Cancers(2024)10.3390/cancers16091779

N/A

0DataRank · unranked

4 citations

Staci N. Keller, Ryan A. Smith, Randy S. Schrecengost, Charles D. Smith, Lynn W. Maines